Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment

Journal of Cataract and Refractive Surgery

Volumn 33, Issue 9, 2007, Pages 1550-1558

  Henderson, Bonnie A ^a   Kim, Jae Yong ^a   Ament, Christine S ^a   Ferrufino Ponce, Zandra K ^a   Grabowska, Anna ^a   Cremers, Sandra L ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; STEROID;

AGED; ARTICLE; CATARACT EXTRACTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE DURATION; EPIRETINAL MEMBRANE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; RETINA VEIN OCCLUSION; RISK FACTOR; TREATMENT DURATION; VISUAL ACUITY;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATARACT EXTRACTION; DIABETES COMPLICATIONS; DRUG THERAPY, COMBINATION; EPIRETINAL MEMBRANE; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INTRAOPERATIVE COMPLICATIONS; MACULAR EDEMA, CYSTOID; MALE; POSTOPERATIVE COMPLICATIONS; PROSTAGLANDINS, SYNTHETIC; PSEUDOPHAKIA; RETINAL VEIN OCCLUSION; RISK FACTORS; TIME FACTORS; VISUAL ACUITY;

EID: 34548156523     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2007.05.013     Document Type: Article

References (50)

1. International Agency for the Prevention of Blindness, under the direction of Sir John Wilson. World Blindness and its Prevention (1980), Oxford University Press, New York, NY
2. National Advisory Eye Council (U.S.). Vision Research: A National Plan: 1983-1987 (1983), U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD NIH Publication no. 83-2473; vol. 2, pt 3
3. Wright P.L., Wilkinson C.P., Balyeat H.D., et al. Angiographic cystoid macular edema after posterior chamber lens implantation. Arch Ophthalmol 106 (1988) 740-744
4. Gass J.D.M., and Norton E.W.D. Follow-up study of cystoid macular edema following cataract extraction. Trans Am Acad Ophthalmol Otolaryngol 73 (1969) 665-681 discussion by AB Reese, 681-682
5. Flach A.J. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 36 (1992) 259-284
6. Ray S., and D'Amico D.J. Pseudophakic cystoid macular edema. Semin Ophthalmol 17 (2002) 167-180
7. Sivaprasad S., Bunce C., and Patel N. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev 25 (2005) CD004239
8. Heier J.S., Topping T.M., Baumann W., et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology 107 (2000) 2034-2038 discussion by AJ Flach, 2039
9. Singal N., and Hopkins J. Pseudophakic cystoid macular edema: ketorolac alone vs. ketorolac plus prednisolone. Can J Ophthalmol 39 (2004) 245-250
10. Pollack A., Leiba H., Bukelman A., et al. The course of diabetic retinopathy following cataract surgery in eyes previously treated by laser photocoagulation. Br J Ophthalmol 76 (1992) 228-231
11. Bradford J.D., Wilkinson C.P., and Bradford Jr. R.H. Cystoid macular edema following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Retina 8 (1988) 161-164
12. O'Brien P.D., Fitzpatrick P., Kilmartin D.J., and Beatty S. Risk factors for endothelial cell loss after phacoemulsification surgery by a junior resident. J Cataract Refract Surg 30 (2004) 839-843
13. Cremers S.L., Ciolino J.B., Ferrufino-Ponce Z.K., and Henderson B.A. Objective Assessment of Skills in Intraocular Surgery (OASIS). Ophthalmology 112 (2005) 1236-1241
14. Miami Study Group. Cystoid macular edema in aphakic and pseudophakic eyes. Am J Ophthalmol 88 (1979) 45-48
15. Stark W.J., Worthen D.M., Holladay J.T., et al. The FDA report on intraocular lenses. Ophthalmology 90 (1983) 311-317
16. Flach A.J. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 96 (1998) 557-634. Available at: http://www.pubmedcentral.nih.gov/tocrender.fcgi?iid=124633 . Accessed May 26, 2007
17. Ursell P.G., Spalton D.J., Whitcup S.M., and Nussenblatt R.B. Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. J Cataract Refract Surg 25 (1999) 1492-1497
18. Miyake K., Ota I., Ibaraki N., et al. Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol 119 (2001) 387-394
19. Yeh P.C., and Ramanathan S. Latanoprost and clinically significant cystoid macular edema after uneventful phacoemulsification with intraocular lens implantation. J Cataract Refract Surg 28 (2002) 1814-1818
20. Alti{dotless}ntaş O., Yüksel N., Karabaş V.L., and Demirci G. Cystoid macular edema associated with latanoprost after uncomplicated cataract surgery. Eur J Ophthalmol 15 (2005) 158-161
21. Moroi S.E., Gottfredsdottir M.S., Schteingart M.T., et al. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology 106 (1999) 1024-1029
22. Henry M.M., Henry L.M., and Henry L.M. A possible cause of chronic cystic maculopathy. Ann Ophthalmol 9 (1977) 455-457
23. Holekamp N.M. Treatment of pseudophakic CME. Ocul Immunol Inflamm 6 (1998) 121-123
24. Milch F.A., and Yannuzzi L.A. Medical and surgical treatment of aphakic cystoid macular edema. Int Ophthalmol Clin 27 3 (1987) 205-217
25. Gass J.D.M., and Norton E.W.D. Cystoid macular edema and papilledema following cataract extraction; a fluorescein funduscopic and angiographic study. Arch Ophthalmol 76 (1966) 646-661
26. Jaffe N.S., Clayman H.M., and Jaffe M.S. Cystoid macular edema after intracapsular and extracapsular cataract extraction with and without an intraocular lens. Ophthalmology 89 (1982) 25-29
27. Percival P. Clinical factors relating to cystoid macular edema after lens implantation. Am Intra-Ocular Implant Soc J 7 (1981) 43-45
28. Jacobson D.R., and Dellaporta A. Natural history of cystoid macular edema after cataract extraction. Am J Ophthalmol 77 (1974) 445-447
29. Nagpal M., Nagpal K., and Nagpal P.N. Postcataract cystoid macular edema. Ophthalmol Clin North Am 14 4 (2001) 651-659
30. Ruiz R.S., and Saatci O.A. Visual outcome in pseudophakic eyes with clinical cystoid macular edema. Ophthalmic Surg 22 (1991) 190-193
31. Estafanous M.F.G., Lowder C.Y., Meisler D.M., and Chauhan R. Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis. Am J Ophthalmol 131 (2001) 620-625
32. Quinn C.J. Cystoid macular edema. Optom Clin 5 (1996) 111-130
33. Tso M.O.M. Pathology of cystoid macular edema. Ophthalmology 89 (1982) 902-915
34. Krishna R., Meisler D.M., Lowder C.Y., et al. Long-term follow-up of extracapsular cataract extraction and posterior chamber intraocular lens implantation in patients with uveitis. Ophthalmology 105 (1998) 1765-1969
35. Blair N.P., Kim S.H., and Friedlander S.M. Cystoid macular edema after ocular surgery. In: Albert D.M., and Jakobiec F.A. (Eds). Principles and Practice of Ophthalmology. 2nd ed. (2000), Saunders, Philadelphia, PA 2080-2088
36. Onal S., Gozum N., and Gucukoglu A. Visual results and complications of posterior chamber intraocular lens implantation after capsular tear during phacoemulsification. Ophthalmic Surg Lasers Imaging 35 (2004) 219-224
37. Frost N.A., Sparrow J.M., Strong N.P., and Rosenthal A.R. Vitreous loss in planned extracapsular cataract extraction does lead to a poorer visual outcome. Eye 9 (1995) 446-451
38. Balent A., Civerchia L.L., and Mohamadi P. Visual outcome of cataract extraction and lens implantation complicated by vitreous loss. J Cataract Refract Surg 14 (1988) 158-160
39. Kraff M.C., Sanders D.R., Jampol L.M., et al. Prophylaxis of pseudophakic cystoid macular edema with topical indomethacin. Ophthalmology 89 (1982) 885-890
40. Miyake K. Indomethacin in the treatment of postoperative cystoid macular edema. Surv Ophthalmol 28 (1984) 554-568
41. Burnett J., Tessler H., Isenberg S., and Tso M.O.M. Double-masked trial of fenoprofen sodium: treatment of chronic aphakic cystoid macular edema. Ophthalmic Surg 14 (1983) 150-152
42. Flach A.J., Dolan B.J., and Irvine A.R. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol 103 (1987) 479-486
43. Flach A.J., Jampol L.M., Weinberg D., et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 112 (1991) 514-519
44. O'Brien T.P. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin 21 (2005) 1131-1137 erratum, 1431-1432
45. Rho D.S. Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac. J Cataract Refract Surg 29 (2003) 2378-2384
46. Yannuzzi L.A., Klein R.M., Wallyn R.H., et al. Ineffectiveness of indomethacin in the treatment of chronic cystoid macular edema. Am J Ophthalmol 84 (1977) 517-519
47. Abbasoǧlu O.E., Hoşal B., Tekeli O., and Gürsel E. Risk factors for vitreous loss in cataract surgery. Eur J Ophthalmol 10 (2000) 227-232
48. Blomquist P.H., and Rugwani R.M. Visual outcomes after vitreous loss during cataract surgery performed by residents. J Cataract Refract Surg 28 (2002) 847-852
49. Fujishima H., Toda I., Yagi Y., and Tsubota K. Quantitative evaluation of postsurgical inflammation by infrared radiation thermometer and laser flare-cell meter. J Cataract Refract Surg 20 (1994) 451-454
50. Jampol L.M., Sanders D.R., and Kraff M.C. Prophylaxis and therapy of aphakic cystoid macular edema. Surv Ophthalmol 28 suppl (1984) 535-539